BCG Treatment for Bladder Cancer: What to Expect
BCG treatment for bladder cancer is an immunotherapy used to treat some forms of non‑muscle invasive bladder cancer (NMIBC), including carcinoma in situ (CIS).
This statement identifies BCG as an immunotherapy for non‑muscle invasive bladder cancer, clarifying its therapeutic role and the specific disease subtype (CIS) it targets. Understanding the mechanism and indication for BCG is essential for clinicians and patients making treatment decisions.
Evidence level: Állatkísérletes. Állatmodellben vizsgálták.